Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000935836-25-000197·Edesa Biotech, Inc.
Schedule 13G ownership disclosure
EDESA BIOTECH INC
Common Stock · CUSIP: 27966L306
Event date: 2025-02-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Stonepine Capital Management, LLC
Shares: 693,551.00 · Class: 9.9%
- Stonepine Capital, L.P.
Shares: 693,551.00 · Class: 9.9%
- Stonepine GP, LLC
Shares: 693,551.00 · Class: 9.9%
- Jon M. Plexico
Shares: 693,551.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000197
- Form type
- SCHEDULE 13G
- Filer
- Edesa Biotech, Inc.
- CIK
- CIK 1540159
- Filed
- Feb 25, 2025
- Reporting period
- Feb 13, 2025
- Description
- Schedule 13G beneficial ownership